The global animal model market size was US$ 1,577.3 million in 2021. The global animal model market is forecast to grow to US$ 2,676.8 million by 2030 by growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period from 2022 to 2030.

Animal models are used by scientists to study & develop the cure for diseases. In this process, final medicinal drugs are tested on animals before carried out the test on humans.

Factors Influencing the Market

The wide range of research activities to develop novel drugs will fuel the growth of the global animal model market. Furthermore, an increase in the adoption of CRISPR technology is expected to offer ample growth opportunities for market growth. The CRISPR technology (Clustered Regularly Interspaced Short Palindromic Repeats) is a time-saving procedure process than conventional technique, which will benefit the animal model market.

The model allows the production of mutant models, such as mutant mouse models, which are highly difficult using conventional technology. As a result, it will surge the growth of the animal model market during the study period.

Stringent regulations related to the use of animals in research may limit the growth of the animal model market. On the contrary, growing investments and other initiatives to boost healthcare infrastructure will further boost the growth of the animal model market during the study period.

COVID-19 Impact Analysis

The wake of the COVID-19 pandemic has surged the range of R&D activities due to varied symptoms and variants. Thus, it also increased the demand for animal models. Moreover, the ongoing pandemic is substantially increasing the demand for more efficient vaccines and models. Thus, it will drive the animal model market forward even in the coming years.

Regional Analysis

The Asia-Pacific animal model market is forecast to emerge as the largest market, owing to the growing preference for animal testing in R&D activities. Furthermore, government support for the development of new novel drugs will also benefit the animal model market during the study period.

Growing implications of mouse clinical trials (MCTs) and ongoing investments in the research activities will benefit the animal model market. The Asia-Pacific animal model market is expected to witness substantial growth opportunities due to the growing range of innovations, the availability of advanced healthcare systems and the rise in pre-clinical activities by CROs. Thus, all of these factors will drive the animal model market forward.

Competitors in the Market

Charles River Laboratories International, Inc
Eurofins Scientific SE
Envigo
GenOway S.A.
JSR Corporation (Crown Bioscience Inc.)
Ozgene Pty Ltd.
PerkinElmer, Inc. (Horizon Discovery Group plc.)
Hera BioLabs (Transposagen Biopharmaceuticals)
Taconic Biosciences
The Jackson Laboratory
Other Prominent Players
Market Segmentation

By Animal Type Outlook

Rat
Mice
Guinea Pigs
Rabbits
Others
By Application Outlook

Drug Discovery & Development
Rat
Mice
Guinea Pigs
Rabbits
Others
Basic Research
Rat
Mice
Guinea Pigs
Rabbits
Others
Others
Rat
Mice
Guinea Pigs
Rabbits
Others
By End-Users Outlook

Pharma & Biotech Companies
Academic Research Institutes
Others
By Regional Outlook

North America
The U.S.
Canada
Mexico
Europe
Western Europe
The UK
Germany
France
Italy
Spain
Rest of Western Europe
Eastern Europe
Poland
Russia
Rest of Eastern Europe
Asia Pacific
China
India
Japan
Australia & New Zealand
ASEAN
Rest of Asia Pacific
Middle East & Africa (MEA)
UAE
Saudi Arabia
South Africa
Rest of MEA
South America
Brazil
Argentina
Rest of South America